Growth Story Still Intact For Allogene Therapeutics Inc (ALLO)
Allogene Therapeutics Inc (ALLO) concluded trading on Thursday at a closing price of $2.61, with 2.65 million shares of worth about $6.91 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -35.56% during that period and on October 03, 2024 the price saw a […]
Is There More Upside Ahead For Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $4.15, with 4.08 million shares of worth about $16.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.95% during that period and on Wednesday February 7 the price saw a […]
Analyst Expect Big Moves From Allogene Therapeutics Inc (NASDAQ: ALLO)
Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]
Institutional Exposure To Allogene Therapeutics Inc (ALLO)
Fidelity Management & Research Co has recently announced that it has increased stake in Allogene Therapeutics Inc (NASDAQ:ALLO) by 0.91%. After grabbing 25.14 million shares, the institutional investor is now in possession of 0.23 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $59.09 […]
Allogene Therapeutics Inc (NASDAQ: ALLO): Hunting Genuine Value In Market Debris
Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]
Investors Should Take Note Of Allogene Therapeutics Inc (ALLO)
Fidelity Management & Research Co has recently announced that it has increased stake in Allogene Therapeutics Inc (NASDAQ:ALLO) by 0.91%. After grabbing 25.14 million shares, the institutional investor is now in possession of 0.23 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 15.00% having worth around $70.91 […]
Allogene Therapeutics Inc (ALLO) Outlook Starting To Look Brighter?
Fidelity Management & Research Co has recently announced that it has increased stake in Allogene Therapeutics Inc (NASDAQ:ALLO) by 0.91%. After grabbing 25.14 million shares, the institutional investor is now in possession of 0.23 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 15.00% having worth around $70.91 […]
